Vesicular Monoamine Transporter 2 Inhibitors

Name
Vesicular Monoamine Transporter 2 Inhibitors
Accession Number
DBCAT004435
Description
Not Available
Drugs
DrugDrug Description
TetrabenazineA vesicular monoamine transporter 2 (VMAT) inhibitor used for the management of chorea associated with Huntington's Disease.
ValbenazineA vesicular monoamine transporter 2 inhibitor used to treat tardive dyskinesia.
Drugs & Drug Targets
DrugTargetType
TetrabenazineSynaptic vesicular amine transportertarget
TetrabenazineCytochrome P450 2D6enzyme
TetrabenazineDopamine D2 receptortarget
TetrabenazineCarbonyl reductase [NADPH] 1enzyme
Valbenazinevesicular monoamine transporter 2 (VMAT2)target
ValbenazineCytochrome P450 2D6enzyme
ValbenazineCytochrome P450 3A4enzyme
ValbenazineCytochrome P450 3A5enzyme